Drug Study Institute (DSI) is a primary care investigative research site dedicated to Quality Investigational New Drug Study. We involve our patients in a drug study as research subject volunteers. We promote access to tomorrow's wonder drugs (pharmaceuticals) today (before the FDA grants approval) in an atmosphere that maximizes benefits and comfort. Patients frequently come back to volunteer as research subjects many times over, telling us they experienced a level of care that's unprecedented. In addition, our patients learn a lot about their disease process and feel they can deal with future healthcare issues better now that they're equipped with the power of knowledge. The word doctore in Latin means "teacher." It is our goal to teach patients enough medicine to empower them to make improved healthcare decisions.
Joseph Saponaro, MD, DABIM, FACP, CPI, CCI, CCTI, CCRC, is the Principal Investigator at DSI. He is a board certified Internist (Diplomat American Board of Internal Medicine) by the ABIM (American Board of Internal Medicine), Fellow American College of Physicians, Certified Physician Investigator by the APPI (Association of Pharmaceutical Physicians and Investigators), Certified Clinical Investigator by the DIA (Drug Information Association), Certified Clinical Trial Investigator and Coordinator by the ACRP (Association of Clinical Research Professionals), Certified Clinical Research Professional by SoCRA (Society of Clinical Research Associates), an IRB member and runs his primary care private practice internal medicine clinic, The Jupiter Preventive Internal Medicine Center, a division of the Jupiter Preventive Medicine Center and DSI (Drug Study Institute). He is also a member of the ACPM (American College of Preventive Medicine), has internal medicine staff privileges at Palm Beach Gardens Medical Center and the Jupiter Medical Center.
Doctor Saponaro is also available for expert medical legal review with ExpertMD.
We devote ourselves to Sponsors and their CRAs. We study and adhere to protocols. We communicate with the Drug Companies and respond to the Data Clarification Forms (queries) in a timely fashion. We orchestrate the drug study in accordance to ICH-GCP. We have to; it's in our SOPs!
We welcome pharmaceutical industry professionals, physicians along with patients/potential research subject volunteers, to look through our web pages. You will find free educational material on drug studies, along with patient-oriented information on what it would be like to be part of the exciting process of advancing medical science by enabling a new experimental medicine to obtain FDA approval and become available on the market to help others.